shark cartilage extract ae-941
Animal productexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Mar 1, 2000 (NCT00005838)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- benfin
- shark cartilage extract ae-941
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00026117 | Phase 3 | Aug 1, 2001 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT00022282 | Phase 2 | Apr 1, 2001 | AEterna Zentaris |
| NCT00005995 | Phase 3 | Oct 1, 2000 | AEterna Zentaris |
| NCT00005838 | Phase 3 | Mar 1, 2000 | National Cancer Institute (NCI), National Center for Complementary and Integrative Health (NCCIH), Radiation Therapy Oncology Group, University of Texas at Houston |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AEterna Zentaris | For profit | 2 | 2 | 2 | 2000 |
| National Cancer Institute (NCI) | Government | 2 | 2 | 1 | 2000 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2001 |
| National Center for Complementary and Integrative Health (NCCIH) | Government | 1 | 0 | 1 | 2000 |
| Radiation Therapy Oncology Group | Academic/Hospital | 1 | 0 | 1 | 2000 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2000 |
6 organizations
Page 1 / 1